← Leaderboards
Jon D Piganelli
University Of Colorado Denver
$2,805,931
Attributed
$2,805,931
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $958.3K · FY2022–25$1M$750K$500K$250K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$2,805,931 · 3
By mechanism
R01$2,204,194 · 1
R21$457,877 · 1
R03$143,860 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Marian J. Rewers$53,889,410
- Kenneth R Teter$7,205,974
- George S Eisenbarth$13,354,570
- Makoto Miyazaki$12,138,675
- Maki Nakayama$6,654,561
Others in their field
Top investigators on “Autoantigens”
- Alessandro Sette · La Jolla Institute For Immunology$40,540,354
- V Michael Holers · University Of Colorado Denver$24,567,150
- Merrill E Gershwin · University Of California At Davis$15,896,665
- Patrick M Gaffney · University Of Minnesota Twin Cities$14,889,699
- Mark S Anderson · University Of California, San Francisco$14,724,222
- Ali Naji · University Of Pennsylvania$13,417,221
Research focus
AutoantigensB-LymphocytesEndoplasmic Reticulum StressOnset Of IllnessInbred Nod MiceAutoimmunityImmuneGenerationsCell PhysiologyIsletAutoimmune DiseasesInsulin-Dependent Diabetes MellitusT-LymphocyteBeta CellAutoreactive T CellCellsCd4 Positive T LymphocytesAntigensCoxsackie B VirusesAutoimmune ResponsesAntigen-Presenting CellsCd8-Positive T-LymphocytesDiabetes MellitusAutoimmune
Grant awards (7)
Examining the Role of CVB in the Generation of Beta Cell Neoantigens and Targeted Approaches at Therapeutic Intervention$500,394
R01 · FY2025 · DK · contact PI
SOLUBLE LYMPHOCYTE ACTIVATION GENE-3 (s-LAG-3) AND INSULIN m-RNA: A POTENTIAL SURROGATE MARKERS FOR DISEASE PROGRESSION AND IMMUNOTHERAPY$457,877
R21 · FY2025 · AI · contact PI
Examining the Role of CVB in the Generation of Beta Cell Neoantigens and Targeted Approaches at Therapeutic Intervention$614,568
R01 · FY2024 · DK · contact PI
Examining the role of CVB in the generation of beta cell neoantigens and targeted approaches at therapeutic intervention$505,766
R01 · FY2023 · DK · contact PI
Examining the role of CVB in the generation of beta cell neoantigens and targeted approaches at therapeutic intervention$583,466
R01 · FY2022 · DK · contact PI
REG. OF T CELL AUTOREACTIVITY IN IDDM BY CTLA-4/CD152$71,930
R03 · FY2001 · DK
REG. OF T CELL AUTOREACTIVITY IN IDDM BY CTLA-4/CD152$71,930
R03 · FY2000 · DK